• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TXG

TXG

10x Genomics, Inc.

NASDAQHealthcareMedical - Healthcare Information ServicesUS

USD32.16

+1.45 (+4.72%)

Rating:C+

Company Profile

CEO

Serge Saxonov

IPO Date

2019-09-12

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Exchange

NASDAQ

Country

US

Market Metrics

Open

$31.17

Prev. Close

$30.71

Day Low

$29.91

Day High

$32.31

52W Low

$8.95

52W High

$32.31

Market Cap

$4.08B

Volume

3.31M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.7%

Avg Negative

13.8%

Avg Neutral

54.4%

News Feed

10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad

GlobeNewsWire·7/27/2021·↓ negative

10x Genomics to Report Second Quarter Financial Results on August 4, 2021

GlobeNewsWire·7/7/2021·↑ positive

These 3 Cathie Wood Stocks Are Still Going Strong

The Motley Fool·6/25/2021·↑ positive

10x Genomics: Promising Growth From A Life Science Leading Single Cell Specialist

Seeking Alpha·5/31/2021·↑ positive

Here's Why 10x Genomics Can't Satisfy Short-Term Investors

The Motley Fool·5/29/2021·↑ positive

Strength Seen in 10x Genomics (TXG): Can Its 3.9% Jump Turn into More Strength?

Zacks Investment Research·5/28/2021·↑ positive

Recap: 10x Genomics Q1 Earnings

Benzinga·5/13/2021·↑ positive

Why Investors Didn't Like 10x Genomics' Q1 Results

The Motley Fool·5/6/2021·↓ negative

10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative